Research Article
Spectrophotometric Determination of Gemifloxacin Mesylate, Moxifloxacin Hydrochloride, and Enrofloxacin in Pharmaceutical Formulations Using Acid Dyes
Table 5
Determination of GMF in its pharmaceutical dosage forms applying the standard addition technique.
| Reagent | Taken (μg mL−1) | Pure drug added (μg mL−1) | Factive tablets | Flobiotic tablet | GemiQue tablets | Total found (μg mL−1) | Recovery %a ± SD | Total found (μg mL−1) | Recovery % ± SD | Total found (μg mL−1) | Recovery % ± SD |
| BCG | 2.0 | 4.0 | 5.96 | 99.30 ± 0.78 | 5.98 | 99.60 ± 0.67 | 6.02 | | | 8.0 | 9.91 | 99.10 ± 1.02 | 10.02 | | 9.92 | | | 12 | 13.97 | 99.80 ± 1.24 | 13.96 | | 13.99 | | BCP
| 2.0 | 2.0 | 3.996 | 99.90 ± 0.66 | 3.96 | | 3.97 | | | 6.0 | 8.02 | 100.20 ± 0.90 | 7.98 | | 7.99 | | | 10 | 11.92 | 99.30 ± 0.95 | 12.05 | | 11.95 | | BPB | 2.0 | 4.0 | 5.97 | 99.50 ± 0.57 | 5.99 | | 6.01 | | | 8.0 | 9.97 | 99.70 ± 0.76 | 9.96 | | 9.97 | | | 12 | 13.87 | 99.10 ± 1.14 | 13.97 | | 13.89 | | BTB | 2.0 | 4.0 | 6.03 | 100.50 ± 0.48 | 6.01 | | 6.01 | | | 8.0 | 9.90 | 99.00 ± 0.72 | 9.96 | | 9.96 | | | 12 | 13.93 | 99.50 ± 0.97 | 13.96 | | 14.04 | | MO | 5.0 | 5.0 | 9.97 | 99.70 ± 0.32 | 9.91 | | 9.99 | | | 10 | 14.94 | 99.60 ± 0.56 | 15.06 | | 14.97 | | | 20 | 24.95 | 99.80 ± 0.90 | 24.88 | | 24.90 | |
|
|
Average of six determinations.
|